JOUNCE THERAPEUTICS INC's ticker is JNCE and the CUSIP is 481116101. A total of 114 filers reported holding JOUNCE THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.78 and the average weighting 0.9%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $1,493,770 | +3.8% | 807,443 | -37.7% | 0.00% | – |
Q4 2022 | $1,439,246 | -5.8% | 1,296,618 | +98.6% | 0.00% | – |
Q3 2022 | $1,528,000 | -23.3% | 653,035 | -0.7% | 0.00% | – |
Q2 2022 | $1,993,000 | -44.7% | 657,919 | +23.9% | 0.00% | – |
Q1 2022 | $3,606,000 | -14.8% | 531,029 | +4.8% | 0.00% | – |
Q4 2021 | $4,231,000 | +14.4% | 506,758 | +1.8% | 0.00% | – |
Q3 2021 | $3,700,000 | +24.0% | 497,985 | +13.5% | 0.00% | – |
Q2 2021 | $2,984,000 | -5.1% | 438,765 | +43.3% | 0.00% | – |
Q1 2021 | $3,145,000 | +36.7% | 306,279 | -6.8% | 0.00% | – |
Q4 2020 | $2,301,000 | -16.0% | 328,706 | -2.0% | 0.00% | – |
Q3 2020 | $2,738,000 | +11.6% | 335,546 | -5.7% | 0.00% | – |
Q2 2020 | $2,454,000 | +23.4% | 355,716 | -15.1% | 0.00% | – |
Q1 2020 | $1,989,000 | -44.3% | 418,772 | +2.5% | 0.00% | – |
Q4 2019 | $3,568,000 | +154.7% | 408,691 | -2.8% | 0.00% | – |
Q3 2019 | $1,401,000 | -24.4% | 420,677 | +12.5% | 0.00% | – |
Q2 2019 | $1,852,000 | +17.7% | 374,069 | +47.3% | 0.00% | – |
Q1 2019 | $1,574,000 | +93.8% | 253,895 | +5.4% | 0.00% | – |
Q4 2018 | $812,000 | -52.2% | 240,879 | -7.7% | 0.00% | – |
Q3 2018 | $1,699,000 | -13.3% | 260,989 | +2.1% | 0.00% | – |
Q2 2018 | $1,959,000 | -65.4% | 255,677 | +0.9% | 0.00% | – |
Q1 2018 | $5,661,000 | +143.6% | 253,379 | +39.1% | 0.00% | – |
Q4 2017 | $2,324,000 | -3.1% | 182,160 | +18.3% | 0.00% | – |
Q3 2017 | $2,398,000 | +70.2% | 154,038 | +53.7% | 0.00% | – |
Q2 2017 | $1,409,000 | +40.9% | 100,233 | +120.6% | 0.00% | – |
Q1 2017 | $1,000,000 | – | 45,430 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
TRV GP II, LLC | 572,829 | $1,340,000 | 100.00% |
TRV GP III, LLC | 1,148,780 | $2,688,000 | 1.17% |
COWEN AND COMPANY, LLC | 3,647,430 | $8,535,000 | 0.82% |
Octagon Capital Advisors LP | 1,400,000 | $3,276,000 | 0.56% |
Deep Track Capital, LP | 4,259,653 | $9,968,000 | 0.46% |
PFM Health Sciences, LP | 4,094,488 | $9,581,000 | 0.35% |
RTW INVESTMENTS, LP | 5,106,341 | $11,949,000 | 0.28% |
Omega Fund Management, LLC | 275,513 | $645,000 | 0.24% |
Monarch Partners Asset Management LLC | 228,370 | $534,000 | 0.16% |
Orbimed Advisors | 2,928,900 | $6,854,000 | 0.13% |